Random, Open, Control and Monocentric Clinical Research on Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)
Phase of Trial: Phase IV
Latest Information Update: 04 Apr 2019
Price : $35 *
At a glance
- Drugs Tacrolimus (Primary) ; Prednisone
- Indications Membranous glomerulonephritis
- Focus Therapeutic Use
- 06 Sep 2018 Planned End Date changed from 1 Oct 2020 to 1 Oct 2021.
- 06 Sep 2018 Planned primary completion date changed from 1 Oct 2019 to 1 Oct 2020.
- 06 Sep 2018 Status changed from not yet recruiting to recruiting.